Pharmacogenetics of response to statins: where do we stand?
about
Genetic determinants of statin intoleranceGenome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapySafety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.Pharmacogenomic importance of pravastatin.Systems biology in pharmacogenomic research: the way to personalized prescribing?Towards companion diagnostics for the management of statin therapy.
P2860
Q21245682-CF3FC081-E8FC-4A68-8568-479D6D68766AQ28729086-D1CD046C-552A-48DD-91FE-460B8A70AE25Q35026444-E9DA61AE-6FD9-4080-8DF7-3B0C3D267C97Q36687277-42A94201-7A97-4C2A-BEA8-612DEC67A3CEQ37264531-34BCD452-82AF-45A2-884E-EF9311F8F0D3Q37521054-216B6378-4DF4-46D0-A8B8-2966FB3673FEQ38089842-9BCC9A28-426C-4B8E-B08C-1E927EB0BD2E
P2860
Pharmacogenetics of response to statins: where do we stand?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Pharmacogenetics of response to statins: where do we stand?
@ast
Pharmacogenetics of response to statins: where do we stand?
@en
type
label
Pharmacogenetics of response to statins: where do we stand?
@ast
Pharmacogenetics of response to statins: where do we stand?
@en
prefLabel
Pharmacogenetics of response to statins: where do we stand?
@ast
Pharmacogenetics of response to statins: where do we stand?
@en
P2860
P1476
Pharmacogenetics of response to statins: where do we stand?
@en
P2093
Anke-Hilse Maitland-van der Zee
P2860
P2888
P304
P356
10.1007/S11883-005-0007-3
P577
2005-05-01T00:00:00Z